235 related articles for article (PubMed ID: 8564916)
21. Neuroleptic dosing in chronic schizophrenia: a 10-year follow-up.
Remington GJ; Prendergast P; Bezchlibnyk-Butler KZ
Can J Psychiatry; 1997 Feb; 42(1):53-7. PubMed ID: 9040924
[TBL] [Abstract][Full Text] [Related]
22. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
[TBL] [Abstract][Full Text] [Related]
23. Neuroleptic plasma levels and tardive dyskinesia: a possible link?
Nasrallah HA
Schizophr Bull; 1980; 6(1):4-7. PubMed ID: 6102792
[TBL] [Abstract][Full Text] [Related]
24. Depot neuroleptic therapy: clinical considerations.
Remington GJ; Adams ME
Can J Psychiatry; 1995 Apr; 40(3 Suppl 1):S5-11. PubMed ID: 7627927
[TBL] [Abstract][Full Text] [Related]
25. Low-dose depot medication in schizophrenia.
Burnett PL; Galletly CA; Moyle RJ; Clark CR
Schizophr Bull; 1993; 19(1):155-64. PubMed ID: 8095736
[TBL] [Abstract][Full Text] [Related]
26. [Acute dyskinesia as the cause of jaw dislocation].
Kozian R; Kiszka T; Peter K; Kühne GE
Psychiatr Prax; 1992 Jul; 19(4):119-21. PubMed ID: 1354880
[TBL] [Abstract][Full Text] [Related]
27. Effect of smoking on neuroleptics in schizophrenia.
Salokangas RK; Saarijärvi S; Taiminen T; Lehto H; Niemi H; Ahola V; Syvälahti E
Schizophr Res; 1997 Jan; 23(1):55-60. PubMed ID: 9050128
[TBL] [Abstract][Full Text] [Related]
28. [Neuroleptic low-dose long-term strategy and intermittent therapy strategy in chronic schizophrenia--a critical review].
Hofmann P; Melisch B; Zapotoczky HG; Kulhanek F
Fortschr Neurol Psychiatr; 1993 Jun; 61(6):195-200. PubMed ID: 8101177
[TBL] [Abstract][Full Text] [Related]
29. Maintenance therapy of persons with schizophrenia.
Carpenter WT
J Clin Psychiatry; 1996; 57 Suppl 9():10-8. PubMed ID: 8823345
[TBL] [Abstract][Full Text] [Related]
30. [Incidence of the deficit form in refractory schizophrenia].
Samuelian JC
Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
[TBL] [Abstract][Full Text] [Related]
31. Benefits and limitations of neuroleptics--and other forms of treatment--in schizophrenia.
Marder SR; May PR
Am J Psychother; 1986 Jul; 40(3):357-69. PubMed ID: 2876653
[TBL] [Abstract][Full Text] [Related]
32. The concept of the neuroleptic threshold: an update.
Bitter I; Volavka J; Scheurer J
J Clin Psychopharmacol; 1991 Feb; 11(1):28-33. PubMed ID: 1674947
[TBL] [Abstract][Full Text] [Related]
33. Neuroleptic dose reduction in older psychotic patients.
Harris MJ; Heaton RK; Schalz A; Bailey A; Patterson TL
Schizophr Res; 1997 Oct; 27(2-3):241-8. PubMed ID: 9416653
[TBL] [Abstract][Full Text] [Related]
34. A prospective study of factors influencing adherence to a continuous neuroleptic treatment program in schizophrenia patients during 2 years.
Linden M; Godemann F; Gaebel W; Köpke W; Müller P; Müller-Spahn F; Pietzcker A; Tegeler J
Schizophr Bull; 2001; 27(4):585-96. PubMed ID: 11824485
[TBL] [Abstract][Full Text] [Related]
35. Intermittent medication--an alternative?
Gaebel W
Acta Psychiatr Scand Suppl; 1994; 382():33-8. PubMed ID: 7916527
[TBL] [Abstract][Full Text] [Related]
36. Depot neuroleptics: side effects and safety.
Marder SR
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089
[TBL] [Abstract][Full Text] [Related]
37. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
Meltzer HY; Bobo WV; Lee MA; Cola P; Jayathilake K
Psychiatry Res; 2010 May; 177(3):286-93. PubMed ID: 20378185
[TBL] [Abstract][Full Text] [Related]
38. Decreased urinary peptide excretion in schizophrenic patients after neuroleptic treatment.
Reichelt KL; Teigland-Gjerstad B
Psychiatry Res; 1995 Sep; 58(2):171-6. PubMed ID: 8570770
[TBL] [Abstract][Full Text] [Related]
39. First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies.
Gaebel W; Jänner M; Frommann N; Pietzcker A; Köpcke W; Linden M; Müller P; Müller-Spahn F; Tegeler J
Schizophr Res; 2002 Jan; 53(1-2):145-59. PubMed ID: 11728846
[TBL] [Abstract][Full Text] [Related]
40. Drug treatment of schizophrenia and delusional disorder in late life.
Howard R
Int Psychogeriatr; 1996; 8(4):597-608. PubMed ID: 9147173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
